HPV Vaccine: PANHPVAX

We are testing a new vaccine aimed at generating an immune response against HPV in healthy volunteers. The study will help us understand its safety and how well it is tolerated.

Safety phase (I)Infectious DiseasesOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Universitaetsklinikum Heidelberg AöR
Department of Clinical Pharmacology and Pharmacoepidemiology
Heidelberg, Germany
Sponsor: Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.